InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Dr. Hendrick P. Scholl. Director active across 1 company, notably Belite Bio, Inc.. Cumulatively, 2 reports have been recorded. History available since 16 June 2026. The latest transaction was disclosed on 18 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations